CXCR1 and type 2 diabetes mellitus: The fact that PDGF-CC-induced WAT browning increases glucose tolerance and insulin sensitivity in HFD-induced obese animals suggests that PDGF-CC-induced WAT browning may be considered for treatment of type 2 diabetes in human patients.